Loading…

Aberrant GSTP1 promoter methylation predicts short‐term prognosis in acute‐on‐chronic hepatitis B liver failure

Summary Background Glutathione‐S‐transferase P1 (GSTP1) methylation has been demonstrated to be associated with oxidative stress induced liver damage in acute‐on‐chronic hepatitis B liver failure (ACHBLF). Aim To evaluate the methylation level of GSTP1 promoter in acute‐on‐chronic hepatitis B liver...

Full description

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2015-08, Vol.42 (3), p.319-329
Main Authors: Gao, S., Sun, F.‐K., Fan, Y.‐C., Shi, C.‐H., Zhang, Z.‐H., Wang, L.‐Y., Wang, K.
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Background Glutathione‐S‐transferase P1 (GSTP1) methylation has been demonstrated to be associated with oxidative stress induced liver damage in acute‐on‐chronic hepatitis B liver failure (ACHBLF). Aim To evaluate the methylation level of GSTP1 promoter in acute‐on‐chronic hepatitis B liver failure and determine its predictive value for prognosis. Methods One hundred and five patients with acute‐on‐chronic hepatitis B liver failure, 86 with chronic hepatitis B (CHB) and 30 healthy controls (HC) were retrospectively enrolled. GSTP1 methylation level in peripheral mononuclear cells (PBMC) was detected by MethyLight. Clinical and laboratory parameters were obtained. Results GSTP1 methylation levels were significantly higher in patients with acute‐on‐chronic hepatitis B liver failure (median 16.84%, interquartile range 1.83–59.05%) than those with CHB (median 1.25%, interquartile range 0.48–2.47%; P 
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.13271